Andrean L. Simons Interdisciplinary Graduate Program in Human Toxicology University of Iowa Biography Publications Institution JoVE Articles Andrean L. Simons has not added a biography. If you are Andrean L. Simons and would like to personalize this page please email our Author Liaison for assistance. Publications Ketogenic Diet with Concurrent Chemoradiation in Head and Neck Squamous Cell Carcinoma: Preclinical and Phase 1 Trial Results Radiation Research. Jun, 2021 | Pubmed ID: 34087943 The Anti-tumor Effects of Cetuximab in Combination with VTX-2337 Are T Cell Dependent Scientific Reports. Jan, 2021 | Pubmed ID: 33452311 Combining Doxorubicin-Loaded PEGylated Poly(Lactide-co-glycolide) Nanoparticles with Checkpoint Inhibition Safely Enhances Therapeutic Efficacy in a Melanoma Model ACS Biomaterials Science & Engineering. 05, 2020 | Pubmed ID: 33463284 Immunization of a TLR9 Agonist Virus-like Particle Enhances Anti-PD1 Therapy Journal for Immunotherapy of Cancer. 10, 2020 | Pubmed ID: 33060147 A Preliminary Analysis of Interleukin-1 Ligands As Potential Predictive Biomarkers of Response to Cetuximab Biomarker Research. 2019 | Pubmed ID: 31346466 Impact of Nuclear Interleukin-1 Alpha and EGFR Expression on Recurrence and Survival Outcomes in Oral Squamous Cell Carcinomas Journal of Oncology. 2019 | Pubmed ID: 31320902 Interleukin-1 Alpha Increases Anti-tumor Efficacy of Cetuximab in Head and Neck Squamous Cell Carcinoma Journal for Immunotherapy of Cancer. 03, 2019 | Pubmed ID: 30890189 Interleukin-1 Blockade Overcomes Erlotinib Resistance in Head and Neck Squamous Cell Carcinoma Oncotarget. Nov, 2016 | Pubmed ID: 27738319 2-Deoxy-d-glucose Suppresses the In Vivo Antitumor Efficacy of Erlotinib in Head and Neck Squamous Cell Carcinoma Cells Oncology Research. 2016 | Pubmed ID: 27178822 Upregulated Interleukin-6 Expression Contributes to Erlotinib Resistance in Head and Neck Squamous Cell Carcinoma Molecular Oncology. Aug, 2015 | Pubmed ID: 25888065 MyD88-Dependent Signaling Decreases the Antitumor Efficacy of Epidermal Growth Factor Receptor Inhibition in Head and Neck Cancer Cells Cancer Research. Apr, 2015 | Pubmed ID: 25712126 EGFR Inhibition Induces Proinflammatory Cytokines Via NOX4 in HNSCC Molecular Cancer Research : MCR. Dec, 2013 | Pubmed ID: 24048704 NOX4 Mediates Cytoprotective Autophagy Induced by the EGFR Inhibitor Erlotinib in Head and Neck Cancer Cells Toxicology and Applied Pharmacology. Nov, 2013 | Pubmed ID: 23917044 The Justy Mutant Mouse Strain Produces a Spontaneous Murine Model of Salivary Gland Cancer with Myoepithelial and Basal Cell Differentiation Laboratory Investigation; a Journal of Technical Methods and Pathology. Jun, 2013 | Pubmed ID: 23608756 Regulation of Pancreatic Cancer Growth by Superoxide Molecular Carcinogenesis. Jul, 2013 | Pubmed ID: 22392697 Susceptibility of Human Head and Neck Cancer Cells to Combined Inhibition of Glutathione and Thioredoxin Metabolism PloS One. 2012 | Pubmed ID: 23118946 Erlotinib-mediated Inhibition of EGFR Signaling Induces Metabolic Oxidative Stress Through NOX4 Cancer Research. Jun, 2011 | Pubmed ID: 21482679 Glucose Deprivation-induced Metabolic Oxidative Stress and Cancer Therapy Journal of Cancer Research and Therapeutics. Sep, 2009 | Pubmed ID: 20009288 Inhibition of Glutathione and Thioredoxin Metabolism Enhances Sensitivity to Perifosine in Head and Neck Cancer Cells Journal of Oncology. 2009 | Pubmed ID: 19746172 Mitochondrial Electron Transport Chain Blockers Enhance 2-deoxy-D-glucose Induced Oxidative Stress and Cell Killing in Human Colon Carcinoma Cells Cancer Biology & Therapy. Jul, 2009 | Pubmed ID: 19411865 Cisplatin Combined with Zidovudine Enhances Cytotoxicity and Oxidative Stress in Human Head and Neck Cancer Cells Via a Thiol-dependent Mechanism Free Radical Biology & Medicine. Jan, 2009 | Pubmed ID: 18983911 2-Deoxyglucose Combined with Wild-type P53 Overexpression Enhances Cytotoxicity in Human Prostate Cancer Cells Via Oxidative Stress Free Radical Biology & Medicine. Mar, 2008 | Pubmed ID: 18155176 Enhanced Response of Human Head and Neck Cancer Xenograft Tumors to Cisplatin Combined with 2-deoxy-D-glucose Correlates with Increased 18F-FDG Uptake As Determined by PET Imaging International Journal of Radiation Oncology, Biology, Physics. Nov, 2007 | Pubmed ID: 17967311 2-Deoxy-D-glucose Combined with Cisplatin Enhances Cytotoxicity Via Metabolic Oxidative Stress in Human Head and Neck Cancer Cells Cancer Research. Apr, 2007 | Pubmed ID: 17409446 Оценка противоопухолевой активности полиангидридных наночастиц IL-1α in vivo M. M. Hasibuzzaman1,2, Kathleen A. Ross3,4, Aliasger K. Salem1,4,5,6, Balaji Narasimhan3,4, Andrean L. Simons1,2,3,5,6,7 1Interdisciplinary Graduate Program in Human Toxicology, University of Iowa, 2Department of Pathology, University of Iowa, 3Department of Chemical and Biological Engineering, College of Engineering, Iowa State University, 4Nanovaccine Institute, Iowa State University, 5Division of Pharmaceutics and Translational Therapeutics, College of Pharmacy, University of Iowa, 6Holden Comprehensive Cancer Center, University of Iowa, 7Department of Oral Pathology, Radiology and Medicine, College of Dentistry, University of Iowa JoVE 62683 Cancer Research
Оценка противоопухолевой активности полиангидридных наночастиц IL-1α in vivo M. M. Hasibuzzaman1,2, Kathleen A. Ross3,4, Aliasger K. Salem1,4,5,6, Balaji Narasimhan3,4, Andrean L. Simons1,2,3,5,6,7 1Interdisciplinary Graduate Program in Human Toxicology, University of Iowa, 2Department of Pathology, University of Iowa, 3Department of Chemical and Biological Engineering, College of Engineering, Iowa State University, 4Nanovaccine Institute, Iowa State University, 5Division of Pharmaceutics and Translational Therapeutics, College of Pharmacy, University of Iowa, 6Holden Comprehensive Cancer Center, University of Iowa, 7Department of Oral Pathology, Radiology and Medicine, College of Dentistry, University of Iowa JoVE 62683 Cancer Research